Expression of aberrant β-catenin and impaired p63 in craniopharyngiomas

References

• Bunin GR, Surawicz TS, Witman PA, et al The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;89(4):547–551.
   PubMedGoogle Scholar
• Louis DN, Ohgaki H, Wiestler OD, et al The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109, 238–40.
   PubMed Web of Science ®Google Scholar
• Hassanein AM, Glanz SM, Kessler HP, et al Beta-catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. Am J Clin Pathol 2003;120:732–736.
   PubMedGoogle Scholar
• Kato K, Nakatani Y, Kanno H, et al Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 2004;203:814–821.
   PubMed Web of Science ®Google Scholar
• Hofmann BM, Kreutzer J, Saeger W, et al Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and Rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 2006;30(12):1595–1603.
   PubMedGoogle Scholar
• Sekine S, Sato S, Takata T, et al Beta-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas. Am J Pathol 2003;163(5):1707–1712.
   PubMedGoogle Scholar
• Hölsken A, Kreutzer J, Hofmann BM, et al Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas. Brain Pathol 2009;19:357–364.
   PubMedGoogle Scholar
• Buslei R, Nolde M, Hofmann B, et al Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathol 2005;109(6):589–597.
   PubMedGoogle Scholar
• Liu X, Rubin JS, Kimmel AR. Rapid, Wnt-induced changes in GSK3beta associations that regulate beta-catenin stabilization are mediated by Galpha proteins. Curr Biol 2005;15:1989–1997.
   PubMed Web of Science ®Google Scholar
• Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781–810.
   PubMed Web of Science ®Google Scholar
• Wikramanayake AH, Hong M, Lee PN, et al An ancient role for nuclear beta-catenin in the evolution of axial polarity and germ layer segregation. Nature 2003;426(6965):446–450.
   PubMedGoogle Scholar
• Buslei R, Holsken A, Hofmann B, et al Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas. Acta Neuropathol (Berl) 2007;113(5):585–590.
   PubMedGoogle Scholar
• Sarubi JC, Bei H, Adams EF, et al Clonal composition of human adamantinomatous craniopharyngiomas and somatic mutation analyses of the patched (PTCH), Gsalpha and Gi2alpha genes. Neurosci Lett 2001;310(1):5–8.
   PubMedGoogle Scholar
• Nozaki M, Tada M, Matsuko R. Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumours of the central nervous system: reappraisal by yeast functional assay. Acta Neuropathol (Berl) 1998;95(3):291–296.
   PubMedGoogle Scholar
• Truong AB, Khavari PA. Control of keratinocyte proliferation and differentiation by p63. Cell Cycle 2007;6(3):295–299.
   PubMedGoogle Scholar
• Foschini MP, Gaiba A, Cocchi R, et al Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 2004;444(4):332–339.
   PubMedGoogle Scholar
• Yang A, Kaghad M, Wang Y, et al P63, a p53 homolog at 3q27 – 29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2(3):305–316.
   PubMedGoogle Scholar
• Osada M, Ohba M, Kawahara C, et al Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998;4(7):839–843.
   PubMedGoogle Scholar
• Kleihues P, Cavenee WK. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press; 2000.
   Google Scholar
• Tomkova K, El-Rifai W, Vilgelm A, et al The gastrin gene promoter is regulated by p73 isoforms in tumor cells. Oncogene 2006;25(44):6032–6036.
   PubMedGoogle Scholar
• Paulus W, Honegger J, Keyvani K, Fahlbusch, Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 1999;97(4):377–382.
   PubMedGoogle Scholar
• Giangaspero F, Burger PC, Osborne DR. Suprasellar papillary squamous epithelioma (“papillary craniopharyngioma”). Am J Surg Pathol 1984;8(1):57–64.
   PubMedGoogle Scholar
• Tanaka Y, Kato K, Notohara K, et al Significance of aberrant (cytoplasmic/nuclear) expression of beta-catenin in pancreatoblastoma. J Pathol 2003;199(2):185–190.
   PubMedGoogle Scholar
• Ohazama A, Tucker A, Sharpe PT. Organized tooth-specific cellular differentiation stimulated by BMP4. J Dent Res 2005;84(7):603–606.
   PubMedGoogle Scholar
• Nakatani Y, Masudo K, Miyagi Y, et al Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of the fetal lung type: up regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Mod Pathol 2002;15(16):617–624.
   PubMedGoogle Scholar
• Kirchner T, Brabletz T. Patterning and nuclear beta-catenin expression in the colonic adenoma-carcinoma sequence. Analogies with embryonic gastrulation. Am J Pathol 2000;157(4):1113–1121.
   PubMedGoogle Scholar
• Di Como CJ, Urist MJ, Babayan I, et al P63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8(2):494–501.
   PubMedGoogle Scholar
• Yamaguchi K, Wu L, Caballero O, et al Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer 2000;86(5):684–689.
   PubMedGoogle Scholar
• Hu H, Xia SH, Li AD, et al Elevated expression of p63 protein in human esophageal squamous cell carcinomas. Int J Cancer 2002;102(6):580–583.
   PubMedGoogle Scholar
• Park BJ, Lee SJ, Kim JI, et al Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 2000;60(13):3370–3374.
   PubMedGoogle Scholar
• Nylander K, Coates PJ, Hall PA. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000;87(3):368–372.
   PubMedGoogle Scholar
• Patturajan M, Nomoto S, Sommer M, et al DeltaNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell 2002;1(4):369–379.
   PubMedGoogle Scholar
• Koga F, Kawakami S, Kumagai J, et al Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. Br J Cancer 2003;88(5):740–747.
   PubMedGoogle Scholar